Release Date: March 14, 2024
Expiration Date: April 18, 2024
Activity Overview
This educational activity is an archive of the live presentation held from March 1 through March 3, 2024, in Miami, FL.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Evaluate current and emerging biomarkers to determine risk and choose therapy for patients with hematologic disorders
- Apply key clinical trial data on current treatment approaches for the management of therapies for patients with hematologic malignancies and classical hematologic disorders
- Identify approaches to mitigate and manage treatment-related adverse events in patients with hematologic disorders
- Examine recent clinical trial results on emerging therapeutic approaches for patients with hematologic disorders
- Investigate clinical implications of evolving therapeutic paradigms in hematologic disorders
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
